表紙
市場調查報告書

硫酸羥氯喹的全球市場的未來展望 (2026年)

Global Hydroxychloroquine Sulphate Market Outlook 2026

出版商 Research Nester 商品編碼 940309
出版日期 內容資訊 英文 117 Pages
商品交期: 最快1-2個工作天內
價格
硫酸羥氯喹的全球市場的未來展望 (2026年) Global Hydroxychloroquine Sulphate Market Outlook 2026
出版日期: 2020年05月01日內容資訊: 英文 117 Pages
簡介

全球硫酸羥氯喹市場在2020∼2026年預測將以5.7%的年複合成長率增長,到2026年終達到14億0570萬美元的規模。

本報告提供全球硫酸羥氯喹市場相關分析,彙整基本的市場結構和最新形勢,相關產業的關聯性,主要的推動及阻礙市場要素,各類型·各用途 (各疾病)的市場趨勢預測 (總計14年份),各地區/主要國家市場詳細趨勢,主要企業的簡介等資訊,為您概述為以下內容。

目錄

第1章 分析概要

第2章 硫酸羥氯喹市場:概要

  • 市場結構
  • 市場定義
  • 市場分類
  • 全球硫酸羥氯喹市場:最新趨勢
  • 產業狀況
    • 產業政策
    • 產品的選拔
    • SWOT分析
    • PEST分析
  • 上游工程 (原料的供給來源),技術·費用
  • 相關產業結構分析
  • 市場流通管道分析
    • 市場流通管道
    • 製造廠房流通
  • 消費者分析:各用途 (各疾病)
  • 市場動態
    • 推動市場要素
    • 阻礙市場要素
    • 市場趨勢
    • 市場機會
    • 新型冠狀病毒感染疾病 (Covid-19) 流行的影響

第3章 全球硫酸羥氯喹市場:各類型 (2014∼2026年)

  • 簡介
  • 市場規模與其預測:各類型
    • 美國藥典條約(USP)標準等級
    • 歐洲藥典(EP)標準等級
    • 醫藥品規格等級
    • 其他

第4章 全球硫酸羥氯喹市場:各用途 (2014∼2026年)

  • 簡介
  • 市場規模與其預測:各用途
    • 風濕關節炎 (RA)
    • 青年性慢性關節炎
    • 鐵餅狀/全身性紅斑性狼瘡
    • 皮膚病變市場區隔

第5章 全球硫酸羥氯喹市場:各地區 (2014∼2026年)

  • 簡介
  • 市場規模與其預測:各地區
    • 中國
    • 美國
    • 歐洲
    • 韓國
    • 印度
    • 日本
    • 東南亞
    • 南美

第6章 中國的硫酸羥氯喹市場:分析與預測 (2014∼2026年)

  • 簡介
    • 中國市場
  • 市場預測:各類型 (2014∼2026年)
  • 市場預測:各用途 (2014∼2026年)
  • 平均銷售價格 (ASP)的分析 (2014∼2026年)

第7章 美國的硫酸羥氯喹市場:分析與預測 (2014∼2026年)

第8章 歐洲的硫酸羥氯喹市場:分析與預測 (2014∼2026年)

第9章 韓國的硫酸羥氯喹市場:分析與預測 (2014∼2026年)

第10章 印度的硫酸羥氯喹市場:分析與預測 (2014∼2026年)

第11章 日本的硫酸羥氯喹市場:分析與預測 (2014∼2026年)

第12章 東南亞的硫酸羥氯喹市場分析與預測,2014∼2026年

第13章 南美的硫酸羥氯喹市場:分析與預測 (2014∼2026年)

第14章 企業簡介

  • SANDOZ INTERNATIONAL GMBH
    • 概況
    • 主要產品/服務的種類
    • 近幾年的主要趨勢
    • SWOT分析
  • TEVA PHARMACEUTICAL INDUSTRIES LTD
  • MYLAN N.V.
  • HIKMA PHARMACEUTICALS PLC
  • IPCA LABORATORIES LIMITED
  • SHANGHAI PHARMACEUTICAL GROUP CO., LTD
  • JIANGSU SHENHUA PHARMACEUTICAL CO., LTD
  • SANOFI S.A.
  • TAJ PHARMACEUTICALS LIMITED
  • MAAN MEDEX PRIVATE LIMITED
  • CINKATE CORPORATION
  • ADVANZ PHARMA CORP
  • SHANGHAI ZHONGXI SANWEI PHARMACEUTICAL CO., LTD

第15章 簡稱一覽

目錄

COVID-19 update included

The content of this report will be updated with the latest scenarios based on the global COVID-19 Pandemic

Hydroxychloroquine sulphate or hydroxychloroquine is an antimalarial drug which is certified and approved for medical use globally for the treatment and prevention of certain types of diseases such as malaria, systemic lupus erythematosus, and rheumatoid arthritis, among several others. The drug is sold under the name Plaquenil and is taken orally. The market for hydroxychloroquine sulfate is projected to grow at a CAGR of 5.7% during the forecast period, i.e, 2020-2026. The market is anticipated to attain a significantly high market value of USD 1,405.7 million by the end of 2026.

Hydroxychloroquine sulphate market is segmented by type, by application and by region, out of which the segment for type is further segmented into USP standard grade, EP standard grade, pharmaceutical standards grade and others. The segment for USP standards grade is predicted to hold the largest share in the market with a market value of around USD 496.4 million by the end of 2026. In addition to this, this segment is projected to grow with the highest growth rate over the forecast period. Based on the application segment, the market for hydroxychloroquine is segmented into rheumatoid joint, adolescent chronic joint, discoid & systemic lupus erythmatosus and skin lesions. Out of these, the segment for rheumatoid joint is anticipated to hold the leading share in the market on account of growing incidences of the disease all over the world.

On the basis of region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. The market in North America is anticipated to witness the highest share in the market with the largest market in the United States, which further is the projected to be the fastest growing market in the region. The market for hydroxychloroquine sulphate in Asia Pacific is estimated to hold the leading share in the market as a result of increasing research and development activities for the manufacture and marketing of this drug.

Some of the key industry leaders in the global hydroxychloroquine sulphate market are: Sandoz International Gmbh, Teva Pharmaceutical Industries Ltd., Mylan N.V., Hikma Pharmaceuticals Plc, Ipca Laboratories Limited, Shanghai Pharmaceutical Group Co., Ltd., Jiangsu Shenhua Pharmaceutical Co., Ltd., Sanofi S.A., Taj Pharmaceuticals Limited and Cinkate Corporation.

TABLE OF CONTENTS

1. Report Overview

  • 1.1. Global Hydroxychloroquine Sulfate Market Overview
  • 1.2. Why You Should Read This Report
  • 1.3. How This Report Delivers
  • 1.4. Key Questions Answered by This Analytical Report
  • 1.5. Who is This Report For?
  • 1.6. Methodology
    • 1.6.1. Primary Research
    • 1.6.2. Secondary Research
    • 1.6.3. Market Evaluation & Forecasting Methodology

2. Introduction to the Hydroxychloroquine Sulfate Market

  • 2.1. Hydroxychloroquine Sulfate Market Structure
  • 2.2. Hydroxychloroquine Sulfate Market Definition
  • 2.3. Global Hydroxychloroquine Sulfate Market Taxonomy
  • 2.4. Global Hydroxychloroquine Sulfate Market Snapshot
  • 2.5. Industry Situation

Industrial Policy

Product Preference

SWOT Analysis

PEST Analysis

  • 2.6. Upstream Source, Technology and Cost

Upstream Source

Technology

Cost

  • 2.7. Hydroxychloroquine Sulphate Industrial Chain Analysis
  • 2.8. Hydroxychloroquine Sulfate Market Channel Analysis
    • 2.8.1. Market Channel
    • 2.8.2. Manufacturing Plants Distribution
  • 2.9. Consumer Analysis
    • 2.9.1. Rheumatoid Joint Industry
    • 2.9.2. Adolescent Chronic Joint Industry
    • 2.9.3. Discoid and Systemic Lupus Erythematosus Industry
    • 2.9.4. Skin Lesions Industry
  • 2.10. Global Hydroxychloroquine Sulfate Market Dynamics
    • 2.10.1. Global Hydroxychloroquine Sulfate Market: Driver
    • 2.10.2. Global Hydroxychloroquine Sulfate Market: Restraints
    • 2.10.3. Global Hydroxychloroquine Sulfate Market: Trends
    • 2.10.4. Global Hydroxychloroquine Sulfate Market: Opportunities
    • 2.10.5. Effect of Hydroxychloroquine Sulfate on Covid-19

3. Global Hydroxychloroquine Sulfate Market, By Types, 2014-2026

  • 3.1. Introduction
  • 3.2. Global Hydroxychloroquine Sulfate Market Size and Forecast, By Types
    • 3.2.1. USP Standards Grade Segment
    • 3.2.2. EP Standards Grade Segment
    • 3.2.3. Pharmaceutical Standards Grade Segment
    • 3.2.4. Others Segment

4. Global Hydroxychloroquine Sulfate Market, By Application, 2014-2026

  • 4.1. Introduction
  • 4.2. Global Hydroxychloroquine Sulfate Market Size and Forecast, By Application
    • 4.2.1. Rheumatoid Joint Segment
    • 4.2.2. Adolescent Chronic Joint Segment
    • 4.2.3. Discoid and Systemic Lupus Erythemato Sus Segment
    • 4.2.4. Skin Lesions Segment

5. Global Hydroxychloroquine Sulfate Market, By Region, 2014-2026

  • 5.1. Introduction
  • 5.2. Global Hydroxychloroquine Sulfate Market Size and Forecast, By Region
    • 5.2.1. China
    • 5.2.2. U.S
    • 5.2.3. Europe
    • 5.2.4. Korea
    • 5.2.5. India
    • 5.2.6. Japan
    • 5.2.7. Southeast Asia
    • 5.2.8. South America

6. China Hydroxychloroquine Sulfate Market Analysis and Forecast, 2014-2026

  • 6.1. Introduction
    • 6.1.1. China
  • 6.2. China Hydroxychloroquine Sulfate Market Forecast, By Types, 2014-2026
  • 6.3. China Hydroxychloroquine Sulfate Market Forecast, By Application, 2014-2026
  • 6.4. China Hydroxychloroquine Sulfate Market, ASP Analysis, 2014-2026

7. U.S. Hydroxychloroquine Sulfate Market Analysis and Forecast, 2014-2026

  • 7.1. Introduction
    • 7.1.1. U.S.
  • 7.2. U.S. Hydroxychloroquine Sulfate Market Forecast, By Types, 2014-2026
  • 7.3. U.S. Hydroxychloroquine Sulfate Market Forecast, By Application, 2014-2026
  • 7.1. U.S. Hydroxychloroquine Sulfate Market, ASP Analysis, 2014-2026

8. Europe Hydroxychloroquine Sulfate Market Analysis and Forecast, 2014-2026

  • 8.1. Introduction
    • 8.1.1. Europe
  • 8.2. EUROPE Hydroxychloroquine Sulfate Market Forecast, By Types, 2014-2026
  • 8.3. EUROPE Hydroxychloroquine Sulfate Market Forecast, By Application, 2014-2026
  • 8.4. EUROPE Hydroxychloroquine Sulfate Market, ASP Analysis, 2014-2026

9. Korea Hydroxychloroquine Sulfate Market Analysis and Forecast, 2014-2026

  • 9.1. Introduction
    • 9.1.1. Korea
  • 9.2. KOREA Hydroxychloroquine Sulfate Market Forecast, By Types, 2014-2026
  • 9.3. KOREA Hydroxychloroquine Sulfate Market Forecast, By Application, 2014-2026
  • 9.4. KOREA Hydroxychloroquine Sulfate Market, ASP Analysis, 2014-2026

10. India Hydroxychloroquine Sulfate Market Analysis and Forecast, 2014-2026

  • 10.1. Introduction
    • 10.1.1. India
  • 10.2. INDIA Hydroxychloroquine Sulfate Market Forecast, By Types, 2014-2026
  • 10.3. INDIA Hydroxychloroquine Sulfate Market Forecast, By Application, 2014-2026
  • 10.4. INDIA Hydroxychloroquine Sulfate Market, ASP Analysis, 2014-2026

11. Japan Hydroxychloroquine Sulfate Market Analysis and Forecast, 2014-2026

  • 11.1. Introduction
    • 11.1.1. Japan
  • 11.2. JAPAN Hydroxychloroquine Sulfate Market Forecast, By Types, 2014-2026
  • 11.3. JAPAN Hydroxychloroquine Sulfate Market Forecast, By Application, 2014-2026
  • 11.4. JAPAN Hydroxychloroquine Sulfate Market, ASP Analysis, 2014-2026

12. Southeast Asia Hydroxychloroquine Sulfate Market Analysis and Forecast, 2014-2026

  • 12.1. Introduction
    • 12.1.1. Southeast Asia
  • 12.2. SOUTHEAST ASIA Hydroxychloroquine Sulfate Market Forecast, By Types, 2014-2026
  • 12.3. SOUTHEAST ASIA Hydroxychloroquine Sulfate Market Forecast, By Application, 2014-2026
  • 12.4. SOUTHEAST ASIA Hydroxychloroquine Sulfate Market, ASP Analysis, 2014-2026

13. South America Hydroxychloroquine Sulfate Market Analysis and Forecast, 2014-2026

  • 13.1. Introduction
    • 13.1.1. South America
  • 13.2. SOUTH AMERICA Hydroxychloroquine Sulfate Market Forecast, By Types, 2014-2026
  • 13.3. SOUTH AMERICA Hydroxychloroquine Sulfate Market Forecast, By Application, 2014-2026
  • 13.4. SOUTH AMERICA Hydroxychloroquine Sulfate Market, ASP Analysis, 2014-2026

14. Company Profiles

  • 14.1. SANDOZ INTERNATIONAL GMBH
    • 14.1.1. Overview
    • 14.1.2. Product Type/Service Offerings
    • 14.1.3. Key Developments
    • 14.1.4. SWOT Analysis
  • 14.2. TEVA PHARMACEUTICAL INDUSTRIES LTD
    • 14.2.1. Overview
    • 14.2.2. Product Type/Service Offerings
    • 14.2.3. Key Developments
    • 14.2.4. SWOT Analysis
  • 14.3. MYLAN N.V.
    • 14.3.1. Overview
    • 14.3.2. Product Type/Service Offerings
    • 14.3.3. Key Developments
    • 14.3.4. SWOT Analysis
  • 14.4. HIKMA PHARMACEUTICALS PLC
    • 14.4.1. Overview
    • 14.4.2. Product Type/Service Offerings
    • 14.4.3. Key Developments: NA
    • 14.4.4. SWOT Analysis
  • 14.5. IPCA LABORATORIES LIMITED
    • 14.5.1. Overview
    • 14.5.2. Product Type/Service Offerings
    • 14.5.3. Key Developments: NA
    • 14.5.4. SWOT Analysis
  • 14.6. SHANGHAI PHARMACEUTICAL GROUP CO., LTD
    • 14.6.1. Overview
    • 14.6.2. Product Type/Service Offerings
    • 14.6.3. Key Developments
    • 14.6.4. SWOT Analysis
  • 14.7. JIANGSU SHENHUA PHARMACEUTICAL CO., LTD
    • 14.7.1. Overview
    • 14.7.2. Product Type/Service Offerings
    • 14.7.3. Key Developments: NA
    • 14.7.4. SWOT Analysis
  • 14.8. SANOFI S.A
    • 14.8.1. Overview
    • 14.8.2. Product Type/Service Offerings
    • 14.8.3. Key Developments
    • 14.8.4. SWOT Analysis
  • 14.9. TAJ PHARMACEUTICALS LIMITED
    • 14.9.1. Overview
    • 14.9.2. Product Type/Service Offerings
    • 14.9.3. SWOT Analysis
  • 14.10. MAAN MEDEX PRIVATE LIMITED
    • 14.10.1. Overview
    • 14.10.2. Product Type/Service Offerings
    • 14.10.3. SWOT Analysis
  • 14.11. CINKATE CORPORATION
    • 14.11.1. Overview
    • 14.11.2. Product Type/Service Offerings
    • 14.11.3. SWOT Analysis
  • 14.12. ADVANZ PHARMA CORP
    • 14.12.1. Overview
    • 14.12.2. Product Type/Service Offerings
    • 14.12.3. Key Developments
    • 14.12.4. SWOT Analysis
  • 14.13. SHANGHAI ZHONGXI SANWEI PHARMACEUTICAL CO., LTD
    • 14.13.1. Overview
    • 14.13.2. Product Type/Service Offerings
    • 14.13.3. SWOT Analysis

15. Acronyms